http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9315406-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36b19bce8760e32c233f01c03e6406f8 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
filingDate | 1993-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde233ed4a139476ad2c1121694afcc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722ff25b57e0c7c30058efcd202135cc |
publicationDate | 1993-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-9315406-A1 |
titleOfInvention | Methods and apparatus for assay of sulphated polysaccharides |
abstract | A method of assaying a sample for sulphated polysaccharide which comprises contacting the sample with (i) a complementary binding polymer capable of binding to said polysaccharide, said binding polymer being labelled with (ii) at least one optically active reporter group, said polymer (i) capable of forming (iii) a complex with said polysaccharide, the reporter group being sensitive to the formation and/or pressure of said complex, and subsequently measuring change in an optical property of the optically labelled polymer as a result of such contact, comparing the change in said optical property with values thereof derived from a control assay for the same polysaccharide, binding polymer and reporter group, and using the comparison of values between the sample and control assays to determine concentration of polysaccharide in said sample. The preferred polysaccharide is heparin, the complementary binding polymer is preferably polycationic polypeptide and the optical property is preferably fluorescence. Assays carried out by the present method can be quicker than previous such assays and may even be appropriate for in vivo use. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7687479-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056504-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939292-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6312906-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119357-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5869517-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0042222-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0042222-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7083937-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709461-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6869789-B2 |
priorityDate | 1992-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.